Lipocine's Licensing Partner, Verity Pharma, Filed A New Drug Submission For Tlando In Canada, Tlando Is The First And Only Oral Testosterone Replacement Therapy Option Approved By FDAThat Does Not Require Dose Titration
Benzinga Newsdesk 1 year ago
BiotechNewsHealth CareGeneral
New Drug Submission filed by Lipocine's licensing partner Verity PharmaOver 700,000 total prescriptions written annually for testosterone replacement therapy (TRT) in Canada, representing large commercial opportunity
- New Drug Submission filed by Lipocine's licensing partner Verity Pharma
- Over 700,000 total prescriptions written annually for testosterone replacement therapy (TRT) in Canada, representing large commercial opportunity